BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17786984)

  • 1. Prediction of pharmaceutical solubility Via NRTL-SAC and COSMO-SAC.
    Tung HH; Tabora J; Variankaval N; Bakken D; Chen CC
    J Pharm Sci; 2008 May; 97(5):1813-20. PubMed ID: 17786984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling.
    Mota FL; Carneiro AP; Queimada AJ; Pinho SP; Macedo EA
    Eur J Pharm Sci; 2009 Jun; 37(3-4):499-507. PubMed ID: 19406228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of solution nonideality of a pseudomorphic drug system through a comprehensive thermodynamic framework for the design of a crystallization process.
    Nordstrom FL; Rasmuson A; Sheikh AY
    J Pharm Sci; 2004 Apr; 93(4):995-1004. PubMed ID: 14999735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design.
    Ruether F; Sadowski G
    J Pharm Sci; 2009 Nov; 98(11):4205-15. PubMed ID: 19283772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection.
    Holaň J; Stěpánek F; Billot P; Ridvan L
    Eur J Pharm Sci; 2014 Oct; 63():124-31. PubMed ID: 24995701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation.
    Abramov YA; Loschen C; Klamt A
    J Pharm Sci; 2012 Oct; 101(10):3687-97. PubMed ID: 22821740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of solubility curves and melting properties of organic and pharmaceutical compounds.
    Nordström FL; Rasmuson AC
    Eur J Pharm Sci; 2009 Feb; 36(2-3):330-44. PubMed ID: 19022383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling and prediction of cocrystal phase diagrams.
    Ainouz A; Authelin JR; Billot P; Lieberman H
    Int J Pharm; 2009 Jun; 374(1-2):82-9. PubMed ID: 19446763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation and prediction of partition coefficient using nonrandom two-liquid segment activity coefficient model for solvent system selection in counter-current chromatography separation.
    Ren DB; Yang ZH; Liang YZ; Ding Q; Chen C; Ouyang ML
    J Chromatogr A; 2013 Aug; 1301():10-8. PubMed ID: 23806351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation--classification and comparison with crystallization tendency from undercooled melts.
    Van Eerdenbrugh B; Baird JA; Taylor LS
    J Pharm Sci; 2010 Sep; 99(9):3826-38. PubMed ID: 20533435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisolvent membrane crystallization of pharmaceutical compounds.
    Di Profio G; Stabile C; Caridi A; Curcio E; Drioli E
    J Pharm Sci; 2009 Dec; 98(12):4902-13. PubMed ID: 19655372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two computational methods for solvent screening in countercurrent and centrifugal partition chromatography.
    Vilas-Boas SM; Cordova IW; Kurnia KA; Almeida HHS; Gaschi PS; Coutinho JAP; Pinho SP; Ferreira O
    J Chromatogr A; 2022 Mar; 1666():462859. PubMed ID: 35124362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of solubility of drugs by conductor-like screening model for real solvents.
    Ikeda H; Chiba K; Kanou A; Hirayama N
    Chem Pharm Bull (Tokyo); 2005 Feb; 53(2):253-5. PubMed ID: 15684531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of In Silico Solvent Screening and an Interactive Web-Based Portal for Pharmaceutical Crystallization Process Development.
    Tan JS; Hilden LR; Merritt JM
    J Pharm Sci; 2019 Aug; 108(8):2621-2634. PubMed ID: 30905703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purely Predicting the Pharmaceutical Solubility: What to Expect from PC-SAFT and COSMO-RS?
    Klajmon M
    Mol Pharm; 2022 Nov; 19(11):4212-4232. PubMed ID: 36136040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the Solubility of Monoterpenoids with Hybrid and Predictive Thermodynamic Tools.
    Vilas-Boas SM; Cordova IW; Abranches DO; Coutinho JAP; Ferreira O; Pinho SP
    Ind Eng Chem Res; 2023 Mar; 62(12):5326-5335. PubMed ID: 37014371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
    Bharate SS; Vishwakarma RA
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1561-7. PubMed ID: 25740159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview and thermodynamic modelling of deep eutectic solvents as co-solvents to enhance drug solubilities in water.
    Zarei A; Haghbakhsh R; Raeissi S
    Eur J Pharm Biopharm; 2023 Dec; 193():1-15. PubMed ID: 37838144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.